Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Business & Regulation

Business & Regulation Drug Discovery

Full SPaeDD Ahead

| Andrew Parker

SPaeDD, a collaborative effort between industry, academia and contractors, is helping to accelerate pediatric drug development in the UK..

Business & Regulation Profession

The Interface Between Art and Science

| Maryam Mahdi

When art and science meet, true inspiration can be found and tapped into.

Business & Regulation Supply Chain

Judging the New Kid on the Block

| Pasi Kemppainen

Is blockchain truly the solution the industry's been looking for?

Business & Regulation Trends & Forecasts

We Must Focus on Science, Not Geography

| Steve Arlington

In times of political and social upheaval, maintaining our links across borders and working closely together is more important than ever.

Business & Regulation Business Practice

Perpetual Preparedness

| James Strachan

With a no-deal Brexit still a real possibility, Merck continues to prepare for the worst case scenario.

Business & Regulation Profession

Foresight is 20/20: Lessons Learned with Claudia Zylberberg

| James Strachan

Claudia Zylberberg reveals her career lessons learned and offers her perspective on the now booming advanced therapies industry.

Business & Regulation Trends & Forecasts

Are You Suffering from Brexit Fatigue?

| James Strachan

The uncertainty surrounding the UK’s future with Europe is having a measurable effect on pharma. But it looks like the end is nowhere in sight.

Business & Regulation Business Practice

Expect the Unexpected

| Yong Guo

Scientific careers are inherently unpredictable, but there are a number of steps we can take to be prepared.

Business & Regulation Supply Chain

The Road to Interoperability

| Maryam Mahdi

The FDA has accepted TraceLink's blockchain and digital recall projects into its DSCSA Pilot Program.

Business & Regulation Clinical Trials

Brexit Realities

| James Strachan

Our animation explores the unique challenges a "no-deal" Brexit poses for the drug development and advanced therapy sectors.

Newsletter

Send me the latest from The Medicine Maker.

Sign up now

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register